Ocrevus®

Ocrevus® (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Genentech

CLASS:
Biologics (CD20 cytolytic antibodies)
WHAT IT TREATS:

Multiple Sclerosis (MS)

PRESCRIBED BY:

Neurologists

HOW ADMINISTERED:
IV infusion
FREQUENCY:

Once every six months

Length of infusion:
Five hours or more